In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens

Nature Medicine

Volumn 8, Issue 4, 2002, Pages 410-414

  Dickinson, Anne M ^a   Wang, Xiao Nong ^a   Sviland, Lisbet ^b   Vyth Dreese, Florry A ^c   Jackson, Graham H ^a   Schumacher, Ton N M ^c   Haanen, John B A G ^c   Mutis, Tuna ^d   Goulmy, Els ^d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GAMMA INTERFERON; HLA ANTIGEN; HY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; PROTEIN HA 1; PROTEIN HA 2; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; EXPLANT; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MINOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; H-Y ANTIGEN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MINOR HISTOCOMPATIBILITY ANTIGENS; NEOPLASM PROTEINS; OLIGOPEPTIDES; SKIN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036107517     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0402-410     Document Type: Article

References (25)

1. Human minor histocompatibility antigens: New concepts for marrow transplantation and adoptive immunotherapy
2. The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism
3. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease
4. An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants
5. Skin explant culture as a model for cutaneous graft-versus-host disease in humans
6. Histopathology of graft-vs-host reaction (GvHR) in human recipients of marrow from HLA-matched sibling donors
7. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: A comparison of T-cell frequency analysis and a human skin explant model
8. A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation
9. Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients
10. Cytokine cascades in acute graft-versus-host disease
11. Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease
12. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens
13. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation
14. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation
15. Prevention of graft versus host disease by inactivation of host antigen-presenting cells
16. + T cells associated with complete molecular remission after donor lymphocyte infusion (DLI) for relapsed CML
17. Generation of allo-HLA restricted minor histocompatibility antigen HA-1 specific cytotoxic T cells as tools for treatment of relapsed leukemia following HLA-mismatched stem cell transplantation
18. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes
19. Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units
20. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation
21. Immunotherapy with CTLs restricted by nonself MHC
22. Selective removal of alloreactive cells from haematopoietic stem cell grafts: Graft engineering for GVHD prophylaxis
23. Immunogenetics of human minor histocompatibility antigens: Their polymorphism and immunodominance
24. Selective expansion of cross-reactive CDB(+) memory T cells by viral variants
25. In situ detection of virus- and tumor-specific T-cell immunity